Global EditionASIA 中文双语Français
Home / World / Asia-Pacific

China's 2nd COVID-19 vaccine candidate allowed late-stage trials in Nepal

Xinhua | Updated: 2021-12-11 22:15
Share - WeChat
FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken on April 10, 2020. [Photo/Agencies]

KATHMANDU -- A COVID-19 vaccine candidate developed by China's WestVac Biopharma Co., Ltd. has received a nod from the Nepali authorities to conduct third-phase clinical trials in the South Asian country, the Nepali government officials said.

"We approved the proposal of WestVac Biopharma Co., Ltd. to conduct third-phase trials for its COVID-19 vaccine candidate last month after it submitted all the necessary documents," Namita Ghimire from the Nepal Health Research Council (NHRC) told Xinhua on Saturday. "The trials will be conducted among people aged 18 and above."

It is the second China-made vaccine and the third COVID-19 vaccine overall to be authorized for late-stage clinical trials in Nepal.

In August, a messenger RNA (mRNA) vaccine jointly developed by China's Suzhou Abogen Biosciences, the Institute of Military Medicine under the Academy of Military Sciences and Walvax Biotechnology Co., Ltd. was greenlighted for trials in the country.

"We have already given approval to WestVac Biopharma Co., Ltd. for the import of its vaccine candidate and conducting clinical trials in Nepal," said Santosh K.C from the Department of Drug Administration.

WestVac Biopharma applied for Nepali trials in August. Ghimire said it was informed that the Chinese company could start trials from January next year.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349